Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis

Michelle J. Ormseth, Patricia G. Yancey, Suguru Yamamoto, Annette M. Oeser, Tebeb Gebretsadik, Ayumi Shintani, MacRae F. Linton, Sergio Fazio, Sean S. Davies, L. Jackson Roberts, Kasey C. Vickers, Paolo Raggi, Valentina Kon, C. Michael Stein

    Research output: Contribution to journalArticle

    4 Scopus citations

    Abstract

    Background/objectives Cardiovascular (CV) risk is increased in patients with rheumatoid arthritis (RA), but not fully explained by traditional risk factors such as LDL and HDL cholesterol concentrations. The cholesterol efflux capacity of HDL may be a better CV risk predictor than HDL concentrations. We hypothesized that HDL's cholesterol efflux capacity is impaired and inversely associated with coronary atherosclerosis in patients with RA. Methods We measured the net cholesterol efflux capacity of apolipoprotein B depleted serum and coronary artery calcium score in 134 patients with RA and 76 control subjects, frequency-matched for age, race and sex. The relationship between net cholesterol efflux capacity and coronary artery calcium score and other clinical variables of interest was assessed in patients with RA. Results Net cholesterol efflux capacity was similar among RA (median [IQR]: 34% removal [28, 41%]) and control subjects (35% removal [27%, 39%]) (P = 0.73). In RA, increasing net cholesterol efflux capacity was not significantly associated with decreased coronary calcium score (OR = 0.78 (95% CI 0.51–1.19), P = 0.24, adjusted for age, race and sex, Framingham risk score and presence of diabetes). Net cholesterol efflux capacity was not significantly associated with RA disease activity score, C-reactive protein, urinary F2-isoprostanes, or degree of insulin resistance in RA. Conclusions Net cholesterol efflux capacity is not significantly altered in patients with relatively well-controlled RA nor is it significantly associated with coronary artery calcium score.

    Original languageEnglish (US)
    Pages (from-to)6-11
    Number of pages6
    JournalIJC Metabolic and Endocrine
    Volume13
    DOIs
    StatePublished - Dec 1 2016

      Fingerprint

    Keywords

    • Atherosclerosis
    • Cholesterol efflux
    • HDL
    • Lipoprotein
    • Rheumatoid arthritis

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Cardiology and Cardiovascular Medicine
    • Physiology (medical)

    Cite this

    Ormseth, M. J., Yancey, P. G., Yamamoto, S., Oeser, A. M., Gebretsadik, T., Shintani, A., Linton, M. F., Fazio, S., Davies, S. S., Roberts, L. J., Vickers, K. C., Raggi, P., Kon, V., & Stein, C. M. (2016). Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis. IJC Metabolic and Endocrine, 13, 6-11. https://doi.org/10.1016/j.ijcme.2016.08.002